FLURAZEPAM HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Flurazepam Hydrochloride patents expire, and what generic alternatives are available?
Flurazepam Hydrochloride is a drug marketed by Chartwell Rx, Halsey, Hikma, Hikma Intl Pharms, Purepac Pharm, Rising, Strides Pharma, Sun Pharm Industries, Superpharm, Usl Pharma, and Warner Chilcott. and is included in twenty-two NDAs.
The generic ingredient in FLURAZEPAM HYDROCHLORIDE is flurazepam hydrochloride. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the flurazepam hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Flurazepam Hydrochloride
A generic version of FLURAZEPAM HYDROCHLORIDE was approved as flurazepam hydrochloride by RISING on November 27th, 1985.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLURAZEPAM HYDROCHLORIDE?
- What are the global sales for FLURAZEPAM HYDROCHLORIDE?
- What is Average Wholesale Price for FLURAZEPAM HYDROCHLORIDE?
Summary for FLURAZEPAM HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 22 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 28 |
Clinical Trials: | 4 |
Patent Applications: | 899 |
DailyMed Link: | FLURAZEPAM HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for FLURAZEPAM HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Saint-Joseph University | Phase 3 |
Hannover Medical School | Phase 3 |
Eisai Inc. | Phase 1 |
Pharmacology for FLURAZEPAM HYDROCHLORIDE
Drug Class | Benzodiazepine |